Objective: To determine the effect of morphine on duration of mechanical ventilation, apnoea and hypotension among full-term neonates who underwent thoracic or abdominal surgery in a level III neonatal intensive care unit.
Introduction
The fact that neonates experience pain and mount a stress response has been established and appreciated. [1] [2] [3] Metabolic and hormonal indicators of the degree of stress a surgical patient experiences have been monitored during and after surgery. 4 Even extremely premature neonates are sufficiently developed, anatomically and physiologically, to be capable of experiencing and responding to pain. 5, 6 The mounting of a surgical stress response results in catabolic responses, including glycogenolysis, gluconeogenesis and lipolysis during the perioperative period. These catabolic responses, when unmodulated by medical intervention, may have a detrimental effect on the clinical course of a neonatal surgical patient. Adverse circulatory and respiratory events are also more likely during the postoperative course of neonates who have had inadequate interventions to minimize stress response. These responses include tachycardia, systemic hypertension, pulmonary hypertension and neuronal excitotoxicity. [7] [8] [9] Furthermore, inadequate treatment of pain in neonates may have implications that extend beyond the neonatal period, including long-lasting changes in pain behaviour. 10 Opioids are the most commonly used analgesics among full-term neonates who have moderate-to-severe postoperative pain. Opioids may be administered safely to neonates when a well-constructed pain management plan is implemented.
11
Morphine is the most commonly used opioid in this population.
The risk of respiratory depression limits clinicians from administering opioids for extended periods of time postoperatively. This is particularly concerning for non-ventilated neonates since there is a paucity of studies that examine the safety of opioids in spontaneously breathing neonates. The present study was conducted to determine the effect of postoperative morphine administration on the duration of mechanical ventilation, hypotension and apnoea among full-term neonates who underwent thoracic or abdominal surgery.
Materials and methods

Study design and setting
Health records and neonatal electronic databases were reviewed retrospectively to identify infants admitted to the out-born neonatal/ surgical neonatal intensive care unit at a tertiary care 
Participants
Neonates aged 0 to 4 weeks (gestational age 36 to 42 weeks; birth weight 2000 g or more) admitted to the neonatal intensive care unit following thoracic or abdominal surgeries were eligible for inclusion. Neonates with multiple congenital anomalies (including congenital CNS anomalies, neuromuscular disorders, congenital heart defects, chromosomal abnormalities and genitourinary abnormalities) or with hypoxic ischaemic encephalopathy or intrauterine growth restriction were excluded. Other exclusion criteria were maternal opioid use or abuse and postoperative administration of neuromuscular blockers.
Data collection
Medical records of infants were reviewed retrospectively and data including patient demographics, clinical diagnosis, type of surgery, postoperative opioid administration, postoperative duration of mechanical ventilation, hypotension (defined by the need for intravenous (i.v.) vasopressor support or i.v. fluid boluses), apnoea (defined by a respiratory pause >20 s or a shorter pause associated with cyanosis, pallor, hypotonia or bradycardia <100 b.p.m) and premature infant pain profile scores (PIPP) were collected. The PIPP score 12, 13 takes into account a total of seven items: facial actions (brow bulge, eye squeeze, nasolabial furrow), physiological indicators (heart rate, oxygen saturation) and context (gestational age, behavioural state). The total scores in this study ranged from 1 to 21, and PIPP scores were collected in 6-h intervals during continuous analgesia.
The study protocol was approved by the Hospital Research Ethics Board.
Data analyses
Descriptive statistics such as mean and standard deviation for continuous data and odds ratio (OR) with 95% confidence intervals for categorical variables are reported. Univariate and multivariate linear regression were performed to determine the effects of cumulative dosage (mg kg À1 ) and duration of morphine infusion (hours) on the primary outcome (duration of mechanical ventilation in hours). Logistic regression was used to assess the significance of duration of morphine and morphine dosage on secondary outcomes (hypotension and apnoea). The relationship between mean pain scores (scores on the PIPP) and mean morphine dosages across time was evaluated by Pearson correlation. Figures are expressed as mean±s.d. A P-value of 0.05 was considered significant.
Results
Of the 368 neonates screened, 82 met the inclusion criteria and they were eligible for enrolment. Patient demographics and reasons for surgery are summarized in Table 1 .
Sixty-two neonates (76%) received morphine and 1 (1%) received fentanyl following surgery as a continuous intravenous infusion; 19 (23%) were given no opioids. The mean dosage of morphine infusion was 10.4±7.7 mg kg À1 h À1 (range 0 to 46 mg kg À1 h À1 ). The median duration of morphine infusion was 43.7 h (upper and lower quartiles: 0.77, 84.60 h) and the median duration of mechanical ventilation was 20.9 h, (upper and lower quartiles: 3.4, 53.5 h). Linear regression analysis showed that the duration of mechanical ventilation was significantly related to morphine dosage (R 2 ¼ 0.19; P<0.0001), as well as the duration of morphine infusion (R 2 ¼ 0.60; P<0.0001). These significant associations persisted after adjusting for type of surgery in a multivariate linear regression model (R 2 ¼ 0.25; P ¼ 0.0007 and R 2 ¼ 0.60; P<0.0001, respectively). An increase in morphine infusion rate by 10 mg kg À1 h À1 was associated with an increase in the duration of mechanical ventilation by 24 h (P<0.0001), and an increase in morphine duration of 1 h was associated with a longer duration of mechanical ventilation by 38 min (0.63 h) (P<0.0001).
Nineteen (23%) infants experienced hypotension during treatment with morphine; hypotension occurred at a mean time interval of 25.6 h (±21.4) after starting morphine infusion; no association was found between the occurrence of hypotension and duration of morphine infusion or morphine dose in these neonates ( Table 2 ). The mean dosage of morphine infusion within the 6 h preceding extubation was 11.8±5.7 mg kg À1 h À1 . None of the Safety profile of morphine following surgery in neonates MF El Sayed et al infants required additional morphine doses, and none experienced failed extubation. Of the 63 neonates who received opioids, 45 (71%) received morphine following extubation; of these non-ventilated infants, 27 (60%) experienced apnoea. All apnoeic episodes were selfresolving and required no intervention. The mean dosage of morphine infusion being administered at time of extubation was 11.2±5.5 mg kg À1 h À1 . Logistic regression analysis showed no association between apnoea and morphine infusion dosage or duration in these neonates (Table 2) .
Mean PIPP scores were correlated with mean morphine dosages across time (r ¼ 0.47; P<0.01); a higher PIPP score was significantly associated with an increase in morphine infusion rate (Figure 1) .
Discussion
This study demonstrated that continuous morphine infusion for postoperative pain is associated with a longer duration of mechanical ventilation among full-term neonates undergoing surgery. Studies carried out in mechanically ventilated preterm neonates have also shown that morphine and fentanyl may prolong the duration of ventilation.
14 The present study replicates this finding in full-term neonates, and therefore this phenomenon may be generalized across a wide gestational age range. In another study comparing the effects of intermittent morphine vs continuous morphine in postoperative full-term infants, no threshold serum concentration of morphine could be confirmed for ventilatory depression. 15 This is the first study to examine the influence of postoperative morphine infusion on the duration of assisted ventilation among full-term neonates; moreover, this study is the first to determine dosage and duration for morphine infusion for effects on mechanical ventilation.
In this small series of 82 neonates, we observed no statistically significant association between morphine dosage or duration of infusion and incidence of apnoea. In other words, the incidence of apnoea was not dose-dependent. There was a high frequency of apnoea following extubation (60%); however, it was self-resolving. Other investigators have similarly reported no clinically significant respiratory depression related to continuous morphine infusion among spontaneously breathing full-term neonates in the paediatric surgical intensive care unit. 16 In the present study, a morphine dosage of 11.2 mg kg À1 h À1 (±5.5) administered to non-ventilated term infants did not appear to cause clinically significant respiratory depression. Further study of the safety/ efficacy profile of morphine will be needed before it can be used routinely in this setting.
Similarly, the incidence of hypotension was not related to the dosage or duration of morphine infusion. Hypotension has also been associated with morphine infusions in previous trials, 11, 17 where the incidence was greater than 25% among preterm infants in the first 24 h of morphine infusion and in those who were hypotensive before morphine therapy. Our findings here may represent a more mature group of neonates, as in contrast to Anand's study all our study infants were greater than 36 weeks gestation.
Pain scores were relatively low throughout the study (mean values p6), as it is thought that scores of 0 to 6 reflect no pain, 6 to 12 reflect mild to moderate pain and above 12 indicate severe pain. 12 All infants received analgesics during the operative procedure (either fentanyl or morphine). Despite the low pain scores, all infants received additional analgesics on return to the neonatal intensive care unit, primarily continuous intravenous morphine infusion at a mean starting dose of 9.8 mg kg À1 h À1 (±7.1), range 0 to 20 mg kg À1 h À1 . The main limitations to this study were the retrospective study design, the lack of placebo, no drug, or other non-opioid analgesics or sedatives, and the small sample size.
Even though morphine dosing in this study was similar to that recommended in previous studies, 16, 18 clinicians may have given more morphine to sick infants with the aim of keeping them mechanically ventilated. Further, we limited our study to postoperative thoracic or abdominal surgery; this study included patients following heterogeneous surgeries and this may impact on pain as well as analgesic requirements. However, as this is the normal population in our neonatal surgical intensive care unit and likely in others, we think that knowledge gained from this heterogeneous population contributes to providing important information that may stimulate further research.
Conclusions
Our data suggest that the dosage and duration of morphine infusion may prolong postoperative duration of mechanical ventilation. There were no significant dose-dependent effects on other parameters including apnoea and hypotension following extubation in term neonates. More research is needed to determine the safety profile of morphine for management of pain in non-ventilated neonates.
